Abstract
External validation of clinical AI emphasizes discrimination, although deployment requires the endpoint, probability estimates and operating policy to transport. Here we show that these layers diverged in retrospective bidirectional evaluation of five model families across eICU and MIMIC-IV. Coarse-label AUROC fell from 0.87–0.92 internally to 0.66–0.83 during source-only transfer. For assessment-conditioned repeated monitoring of persistence or recurrence, external AUROC reached 0.76–0.94, but removing assessment history reduced it by 0.16–0.32; broader features did not help consistently. Transported scores concentrated future-positive ICU stays 2.4–6.9-fold in the top risk decile. Development-selected cutoffs alerted 0.3–2.0% of prediction rows and captured 9.2–11.0% of future-positive rows; after deduplication, 4.9–12.2% of stays were alerted, capturing 43.9–49.4% of future-positive stays. Thus, ranking can persist while probability and policy transport remain site dependent. Layered validation is a prerequisite for prospective evaluation, not evidence of clinical benefit.
Competing Interest Statement
The authors have declared no competing interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This retrospective secondary analysis used pre-existing, de-identified data from MIMIC-IV v3.1 and the eICU Collaborative Research Database v2.0. Both databases were accessed through PhysioNet after individual credentialing, completion of the required CITI training and execution of the applicable data use agreements. No identifiable patient information was accessed. No additional participant consent was required.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
This study used the eICU Collaborative Research Database version 2.0 and MIMIC-IV version 3.1. Both datasets are available through PhysioNet to credentialed users who complete the required human-research training and sign the applicable data-use agreement (eICU: https://doi.org/10.13026/C2WM1R; MIMIC-IV: https://doi.org/10.13026/kpb9-mt58).
Funder Information Declared
